Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fulgent Genetics (FLGT)
:FLGT
Holding FLGT?
Track your performance easily
FLGT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$16.56 - $26.91
Previous CloseN/A
Volume61.15K
Average Volume (3M)262.09K
Market Cap
$535.27M
Enterprise Value$454.27M
Total Cash (Recent Filing)$20.87M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Feb 27, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.53
Shares Outstanding30,586,811
10 Day Avg. Volume204,861
30 Day Avg. Volume262,086
Standard Deviation0.23
R-Squared0.10
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.93
Price to Cash Flow (P/CF)-8.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue1.64
Enterprise Value/Gross Profit4.35
Enterprise Value/Ebitda-9.83
Forecast
1Y Price Target
$22.00Price Target Upside25.71% Upside
Rating ConsensusHold
Number of Analyst Covering1
Fulgent Genetics News
PremiumCompany Announcements
Fulgent Genetics Reports Q3 2024 Financial Performance
PremiumCompany Announcements
Fulgent Genetics Reports Strong Q3 2024 Results
Ownership Overview
34.47% Insiders
11.75% Mutual Funds
<0.01% Other Institutional Investors
35.77% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FLGT FAQ
What was Fulgent Genetics’s price range in the past 12 months?
Fulgent Genetics lowest stock price was $16.56 and its highest was $26.91 in the past 12 months.
What is Fulgent Genetics’s market cap?
Fulgent Genetics’s market cap is $535.27M.
When is Fulgent Genetics’s upcoming earnings report date?
Fulgent Genetics’s upcoming earnings report date is Feb 27, 2025 which is in 40 days.
How were Fulgent Genetics’s earnings last quarter?
Fulgent Genetics released its earnings results on Nov 08, 2024. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of -$0.154 by $0.464.
Is Fulgent Genetics overvalued?
According to Wall Street analysts Fulgent Genetics’s price is currently Undervalued.
Does Fulgent Genetics pay dividends?
Fulgent Genetics does not currently pay dividends.
What is Fulgent Genetics’s EPS estimate?
Fulgent Genetics’s EPS estimate is -0.12.
How many shares outstanding does Fulgent Genetics have?
Fulgent Genetics has 30,586,811 shares outstanding.
What happened to Fulgent Genetics’s price movement after its last earnings report?
Fulgent Genetics reported an EPS of $0.31 in its last earnings report, beating expectations of -$0.154. Following the earnings report the stock price went down -11.762%.
Which hedge fund is a major shareholder of Fulgent Genetics?
Currently, no hedge funds are holding shares in FLGT
---
Fulgent Genetics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$22.00 (25.71% Upside)
$22.00 (25.71% Upside)
Blogger Sentiment
Bullish
FLGT Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 19.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $117.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 4.4%
Last 30 Days ▲ 4.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.53%
12-Months-Change
Fundamentals
Return on Equity
-13.76%
Trailing 12-Months
Asset Growth
-9.18%
Trailing 12-Months
Company Description
Fulgent Genetics
Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.
---
FLGT Company Deck
---
FLGT Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there are significant achievements in precision diagnostics growth, new contracts, and advancements in therapeutic development, challenges remain with declining total revenue, impairment charges, and operating margin pressures. The company's strong balance sheet and strategic initiatives provide a positive outlook for future growth.Read More>---
Technical Analysis
---